{"nct_id":"NCT02184572","title":"Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age","status":"COMPLETED","status_verified_date":"2020-12","start_date":"2014-08-25","start_date_type":"ACTUAL","primary_completion_date":"2015-08-14","primary_completion_date_type":"ACTUAL","completion_date":"2015-12-22","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}